ChEMBL ID: CHEMBL2109268
Mechanism of action: Leukocyte antigen CD37 binding agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to NARATUXIMAB EMTANSINE